Treatment effect and prediction survival of Immune checkpoint inhibitors by FDG-PET/CT: A multicenter study - Trial UMIN000047230
Access comprehensive clinical trial information for UMIN000047230 through Pure Global AI's free database. This Not Applicable trial is sponsored by Hyogo College of Medicine and is currently Not yet recruiting. The study focuses on Lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000047230
Not Applicable
Not yet recruiting
other
Trial Details
University Hospital Medical Information Network • UMIN000047230
Treatment effect and prediction survival of Immune checkpoint inhibitors by FDG-PET/CT: A multicenter study
Treatment effect and prediction survival of Immune checkpoint inhibitors by FDG-PET: A multicenter prospective study
Study Focus
Sponsor & Location
Hyogo College of Medicine
Japan
Timeline & Enrollment
Not Applicable
Aug 01, 2022
N/A
ICD-10 Classifications
Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000047230
Non-Device Trial